Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer

BACKGROUND: A previous phase I/II C-TASK FORCE study of trifluridine/tipiracil plus bevacizumab for patients with heavily pretreated metastatic colorectal cancer (mCRC) showed promising activity with an acceptable toxicity profile. This retrospective study aimed to investigate the safety and efficac...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Kotani, Daisuke, Kuboki, Yasutoshi, Horasawa, Satoshi, Kaneko, Asumi, Nakamura, Yoshiaki, Kawazoe, Akihito, Bando, Hideaki, Taniguchi, Hiroya, Shitara, Kohei, Kojima, Takashi, Tsuji, Akihito, Yoshino, Takayuki
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935149/
https://ncbi.nlm.nih.gov/pubmed/31881856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6475-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados